Gastrointestinal symptoms in neuronal ceroid lipofuscinoses (NCLs): an observational study on prevalence, timing of progression, and impact on quality of life
Neurogenetics · 2025
DOI: 10.1007/s10048-025-00871-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Neurogenetics, 2025. Verfasst von Stefania Della Vecchia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini, 6, Florence, Italy. Hauptthemen laut MEDLINE: Quality of Life, Neuronal Ceroid-Lipofuscinoses, Gastrointestinal Diseases. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Neuronal ceroid lipofuscinoses (NCLs) are rare, inherited lysosomal storage disorders (LSDs) of the brain and retina. Gastrointestinal (GI) manifestations are reported in clinical practice but remain largely underexplored. Lysosomal dysfunction affects both the central and the peripheral nervous systems, including the enteric nervous system (ENS) where accumulation of storage material and neuronal loss may directly contribute to GI dysmotility. These insights, combined with emerging gene therapies targeting both brain and ENS pathology, underscore the need for validated GI endpoints in NCL research. We present a cross-sectional study assessing prevalence, progression, and clinical impact of GI symptoms in an Italian NCL cohort. Using caregiver-reported data and standardized tools - including the PedsQL™ GI Symptoms Scales and the Hamburg rating Scale - we evaluated GI burden and its correlation with neurological severity. Over 60% of caregivers reported GI disturbances, with constipation as the most prevalent and earliest onset symptom. Nutritional issues, such as dysphagia, were common but tended to appear later. GI symptoms correlated well with decline in quality of life, especially for Trouble Swallowing (padj
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Viale Pieraccini, 6, Florence, Italy.
- Molecular Medicine Unit, IRCCS Fondazione Stella Maris, Pisa, 56128, Calambrone, Italy.
- Department of Surgery, Dentistry, Pediatrics and Gynecology University of Verona, Verona, 37134, Italy.
- Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa and University Hospital of Pisa, Pisa, Italy.
- Neurology, Epilepsy and Movement Disorders Unit, IRCCS, Full Member of European Reference Network EpiCARE, Bambino Gesù Children's Hospital, Rome, Italy.
- University Hospitals KU, Leuven, Belgium.
Förderung
- Ministero della Salute
Zitieren
APA
Della Vecchia, S., Simonati, A., Manca, M. L., Pietrafusa, N., Trivisano, M., Calabrese, C., Specchio, N., Santorelli, F. M., & A-NCL-ETS (2025). Gastrointestinal symptoms in neuronal ceroid lipofuscinoses (NCLs): an observational study on prevalence, timing of progression, and impact on quality of life. Neurogenetics. https://doi.org/10.1007/s10048-025-00871-2
Vancouver
Della Vecchia S, Simonati A, Manca ML, Pietrafusa N, Trivisano M, Calabrese C, et al. Gastrointestinal symptoms in neuronal ceroid lipofuscinoses (NCLs): an observational study on prevalence, timing of progression, and impact on quality of life. Neurogenetics. 2025. doi:10.1007/s10048-025-00871-2
BibTeX
@article{DellaVecchia2025,
author = {Della Vecchia, Stefania and Simonati, Alessandro and Manca, Maria Laura and Pietrafusa, Nicola and Trivisano, Marina and Calabrese, Costanza and Specchio, Nicola and Santorelli, Filippo Maria and A-NCL-ETS, A-NCL-ETS},
title = {Gastrointestinal symptoms in neuronal ceroid lipofuscinoses (NCLs): an observational study on prevalence, timing of progression, and impact on quality of life},
journal = {Neurogenetics},
year = {2025},
doi = {10.1007/s10048-025-00871-2}
}
EUVIMED